+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Drug Delivery Device Market - Global Forecast 2026-2032- Product Image
Implantable Drug Delivery Device Market - Global Forecast 2026-2032- Product Image
Sale

Implantable Drug Delivery Device Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904899
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Implantable Drug Delivery Device Market is projected to reach USD 29.67 Billion in 2026. It is expected to continue growing at a CAGR of 8.26%, reaching USD 47.86 Billion by 2032.

The implantable drug delivery device market is advancing as healthcare systems prioritize long-acting, targeted, and adherence-supporting therapies for chronic disease, oncology, pain management, ophthalmology, diabetes care, and neurological disorders. These systems include implantable pumps, drug-eluting implants, biodegradable depots, intrathecal delivery platforms, and specialty devices designed to release medication over weeks, months, or years.

Demand is supported by the global burden of noncommunicable diseases, which the World Health Organization identifies as the leading cause of mortality worldwide. For payers and providers, implantable drug delivery devices offer a practical pathway to improve therapeutic consistency, reduce dosing burden, and enable localized delivery that can lower systemic exposure when appropriately designed and clinically validated.

Transformative Shifts in the Market Landscape

The landscape is shifting from passive implants toward programmable, miniaturized, and connected drug delivery systems. Device developers are increasingly combining biocompatible materials, microelectronics, precision reservoirs, and sensor-enabled monitoring to improve dose accuracy, patient safety, and long-term reliability.

Regulation is also reshaping competition. In the United States, many implantable drug delivery products are evaluated as combination products when device and drug functions are integrated. In Europe, the Medical Device Regulation has strengthened clinical evidence and post-market surveillance expectations, increasing the value of robust quality systems, usability engineering, cybersecurity planning, and real-world performance data.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is influencing implantable drug delivery device development through design optimization, predictive maintenance models, patient selection analytics, and clinical workflow automation. AI can help analyze imaging, pharmacokinetic profiles, adherence patterns, and adverse event signals to support more personalized dosing strategies.

The cumulative impact is strongest when AI is governed as a regulated quality process rather than a stand-alone feature. FDA, Health Canada, and the U.K. MHRA have promoted Good Machine Learning Practice principles, while the European Union AI Act adds further accountability for high-risk health technologies. Successful developers are pairing AI-enabled insights with transparent validation, human oversight, data security, and lifecycle monitoring.

Key Regional Insights for Implantable Drug Delivery Devices

Asia-Pacific is emerging as a strategically important region for implantable drug delivery devices due to aging populations, expanding specialty care access, and rising chronic disease treatment needs in China, India, Japan, South Korea, and Australia. Public health data from national and international agencies consistently show increasing demand for long-term management of diabetes, cancer, cardiovascular disease, neurological disorders, and chronic pain across the region. Japan and South Korea offer advanced medtech infrastructure, mature hospital systems, and high clinical standards, while China and India provide scale as hospital networks, domestic medtech capabilities, and reimbursement pathways continue to develop.

North America remains a leading innovation and commercialization hub, supported by established regulatory pathways, strong clinical trial capacity, advanced reimbursement systems, and high adoption of pain management, oncology, diabetes, ophthalmology, and neurological therapies. Europe is defined by rigorous clinical evidence requirements under the Medical Device Regulation, creating a strong emphasis on post-market surveillance, safety documentation, and real-world performance data. Latin America is gaining traction through specialist centers and private healthcare expansion, particularly in urban markets, while the Middle East is supported by investment in tertiary hospitals, national health transformation programs, and digital health infrastructure. Africa presents selective opportunities where specialist referral centers, access initiatives, and public-private healthcare investments are improving availability of advanced implantable therapies.

Key Group Insights Across Major Economic Alliances

Within ASEAN, demand for implantable drug delivery devices is tied to expanding hospital infrastructure, medical tourism, and greater access to chronic disease care, particularly in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. Singapore and Thailand provide sophisticated specialty care environments, while larger ASEAN economies are strengthening access through healthcare modernization and broader insurance coverage. GCC countries are investing in specialty hospitals, national health strategies, and digital health systems, creating opportunities for premium implantable drug delivery platforms in oncology, pain management, diabetes-related care, and complex chronic disease treatment.

The European Union offers a large, harmonized but highly regulated environment where MDR compliance, clinical evidence, post-market performance, and traceability are decisive for adoption. BRICS economies combine population scale with growing domestic manufacturing ambitions, healthcare infrastructure expansion, and policy interest in local medical technology capacity. G7 countries lead in reimbursement sophistication, clinical research, regulatory maturity, and technology adoption, supporting early use of advanced implantable pumps, drug-eluting implants, and connected delivery systems. NATO-aligned healthcare resilience priorities can also influence supply chain security, cybersecurity requirements, and sourcing strategies for critical medical technologies used in complex care settings.

Key Country Insights for Strategic Market Expansion

The United States leads in commercialization, clinical research, venture funding, and adoption of sophisticated implantable drug delivery technologies, supported by advanced specialty care networks and established regulatory review for combination products. Canada emphasizes evidence-based reimbursement, device safety, and health technology assessment. Mexico and Brazil are important access markets in the Americas, with private hospitals, specialty clinics, and urban healthcare systems supporting adoption of advanced drug delivery implants for chronic and complex conditions. In Europe, the United Kingdom, Germany, France, Italy, and Spain offer mature healthcare systems, experienced clinicians, and structured reimbursement evaluation, while Russia presents a more complex environment shaped by localization, procurement considerations, and healthcare system variability.

China and India provide large patient bases, growing specialist capacity, and expanding domestic medtech capabilities, with adoption shaped by pricing, reimbursement, hospital tendering, and local clinical evidence. Japan is characterized by an aging population, strong clinical quality standards, and demand for technologies that support long-term disease management. South Korea combines advanced hospital infrastructure with digital health readiness and strong procedural expertise, while Australia stands out for high regulatory standards, specialist care quality, and evidence-based reimbursement processes. Across these countries, success depends on aligning product design with local reimbursement, physician training, clinical evidence expectations, supply reliability, and dependable after-implant support.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical value, including measurable improvements in adherence, dose precision, safety, quality of life, and total cost of care. Early engagement with regulators, payers, surgeons, pharmacists, and patient advocacy groups can reduce evidence gaps and support more efficient market access planning.

Manufacturers should also invest in biocompatibility testing, human factors engineering, sterile manufacturing, cybersecurity, traceability, and real-world evidence systems. Strategic partnerships with pharmaceutical developers, specialty hospitals, contract manufacturers, academic clinical networks, and digital health providers can strengthen combination-product development and create defensible positions in high-value therapeutic areas.

Research Methodology

This executive summary is grounded in secondary research from recognized public sources, including health agencies, regulatory authorities, standards organizations, clinical trial registries, and peer-reviewed medical literature. Key reference frameworks include FDA combination product guidance, EU MDR requirements, ISO-aligned quality and biocompatibility principles, WHO chronic disease data, and publicly available healthcare infrastructure indicators.

Market interpretation combines qualitative analysis of clinical adoption, regulatory burden, reimbursement maturity, disease prevalence, and technology readiness. Regional, group, and country insights are synthesized through cross-comparison of healthcare expenditure trends, specialty care access, demographic shifts, medtech policy environments, and documented regulatory expectations without using market sizing, market share, or forecasting assumptions.

Conclusion

Implantable drug delivery devices are becoming essential tools for long-acting, targeted, and patient-centered therapy. The strongest opportunities are concentrated in therapeutic areas where sustained dosing, localized delivery, or adherence improvement can produce clinically meaningful outcomes.

Competition will favor organizations that combine engineering reliability, strong clinical evidence, regulatory discipline, scalable manufacturing, and dependable post-implant support. As AI, connectivity, and advanced materials mature, the market is positioned to evolve from device-based delivery toward integrated therapeutic platforms with measurable value for patients, providers, and payers.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Implantable Drug Delivery Device Market, by Product Type
7.1. Introduction
7.2. Contraceptive Implants
7.3. Drug Eluting Stents
7.3.1. Coronary Stents
7.3.2. Peripheral Stents
7.4. Infusion Pumps
7.4.1. Chemotherapy Pumps
7.4.2. Insulin Pumps
7.4.3. Pain Management Pumps
7.5. Microchip Implants
7.6. Osmotic Pumps
8. Implantable Drug Delivery Device Market, by Material Type
8.1. Introduction
8.2. Biodegradable Polymers
8.3. Mechanical Pumps
8.4. Microchip Based
8.4.1. Electromechanical Pumps
8.4.2. MEMS Systems
8.5. Osmotic Pumps
9. Implantable Drug Delivery Device Market, by Drug Type Delivered
9.1. Introduction
9.2. Small Molecule Drugs
9.3. Biologics
9.4. Hormonal Drugs
9.5. Oncologic Drugs
10. Implantable Drug Delivery Device Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Contraception
10.4. Diabetes
10.5. Neurology
10.6. Oncology
10.7. Pain Management
11. Implantable Drug Delivery Device Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Implantable Drug Delivery Device Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. Implantable Drug Delivery Device Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. AbbVie Inc.
15.3. Bausch + Lomb
15.4. BIOTRONIK
15.5. Boston Scientific Corporation
15.6. Charles Stark Draper Laboratory Inc
15.7. Debiotech S.A.
15.8. Delpor Inc.
15.9. DURECT Corporation
15.10. Elixir Medical Corporation
15.11. Enable Injections, Inc.
15.12. EyePoint Pharmaceuticals, Inc.
15.13. Flowonix Medical Inc.
15.14. Idex Corporation
15.15. Insulet Corporation
15.16. Johnson & Johnson
15.17. Medtronic plc
15.18. Merck & Co., Inc.
15.19. NanoPass Technologies Ltd.
15.20. Ocular Therapeutix Inc.
15.21. ReCor Medical, Inc.
15.22. Repligen Corporation
15.23. Roche Holding AG
15.24. Santen Pharmaceutical Co., Ltd.
15.25. Tandem Diabetes Care, Inc.
15.26. Teleflex Incorporated
15.27. Terumo Corporation
15.28. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONTRACEPTIVE IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONTRACEPTIVE IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONTRACEPTIVE IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL CORONARY STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PERIPHERAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PERIPHERAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INFUSION PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CHEMOTHERAPY PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CHEMOTHERAPY PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CHEMOTHERAPY PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PAIN MANAGEMENT PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PAIN MANAGEMENT PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PAIN MANAGEMENT PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MICROCHIP IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MICROCHIP IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MICROCHIP IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL OSMOTIC PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL OSMOTIC PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL OSMOTIC PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MECHANICAL PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MECHANICAL PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MECHANICAL PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MICROCHIP BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MICROCHIP BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MICROCHIP BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ELECTROMECHANICAL PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ELECTROMECHANICAL PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ELECTROMECHANICAL PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MEMS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MEMS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MEMS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL OSMOTIC PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL OSMOTIC PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OSMOTIC PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HORMONAL DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HORMONAL DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HORMONAL DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ONCOLOGIC DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ONCOLOGIC DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ONCOLOGIC DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CONTRACEPTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CONTRACEPTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CONTRACEPTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 94. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 96. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 97. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 98. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 99. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 100. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 101. EUROPE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 118. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 120. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 121. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 122. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 123. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 124. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 125. AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 138. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 139. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 140. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 141. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 142. NATO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 143. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 145. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 146. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 147. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 148. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 149. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 150. G7 IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 154. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 155. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 156. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 157. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 158. BRICS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 169. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 170. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 171. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 172. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 173. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 174. ASEAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 178. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 179. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 180. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 181. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 182. GCC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 184. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 185. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 187. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 188. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 189. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 190. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 191. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 197. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 198. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 199. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 201. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 202. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 203. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 204. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 205. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 206. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 207. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 209. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 211. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 212. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 213. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 214. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 215. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 218. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 219. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 220. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 221. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 222. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 223. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 234. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 235. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 236. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 237. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 238. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 239. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 241. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 243. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 244. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 245. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 246. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 247. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 250. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 251. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 252. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 253. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 254. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 255. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 259. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 260. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 261. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 262. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 263. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 266. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 267. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 268. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 269. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 270. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 271. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 275. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 276. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 277. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 278. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 279. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 283. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 284. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 285. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 286. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 287. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 289. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 290. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 291. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 292. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 294. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 295. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2017-2032 (USD MILLION)
TABLE 299. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 300. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 301. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2017-2032 (USD MILLION)
TABLE 302. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE DELIVERED, 2017-2032 (USD MILLION)
TABLE 303. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 305. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Bausch + Lomb
  • BIOTRONIK
  • Boston Scientific Corporation
  • Charles Stark Draper Laboratory Inc
  • Debiotech S.A.
  • Delpor Inc.
  • DURECT Corporation
  • Elixir Medical Corporation
  • Enable Injections, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Flowonix Medical Inc.
  • Idex Corporation
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Merck & Co., Inc.
  • NanoPass Technologies Ltd.
  • Ocular Therapeutix Inc.
  • ReCor Medical, Inc.
  • Repligen Corporation
  • Roche Holding AG
  • Santen Pharmaceutical Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 29.67 Billion
Forecasted Market Value ( USD ) by 2032 $ 47.86 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Implantable Drug Delivery Devices Market Size, Share, Trends and Forecast by Product Type, Technology, Application, End User, and Region, 2026-2034 - Product Image

Implantable Drug Delivery Devices Market Size, Share, Trends and Forecast by Product Type, Technology, Application, End User, and Region, 2026-2034

  • Report
  • 135 Pages
  • Global
From
Implantable Drug Delivery Devices Market Report 2026 - Product Image

Implantable Drug Delivery Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Implantable Drug Delivery Devices - Global Strategic Business Report - Product Image

Implantable Drug Delivery Devices - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.